BioScrip Stockholders Elect New Independent Director Yon Y. Jorden to Board of Directors

BioScrip Stockholders Elect New Independent Director Yon Y. Jorden to Board of
                                  Directors

PR Newswire

ELMSFORD, N.Y., May 14, 2014

ELMSFORD, N.Y., May 14, 2014 /PRNewswire/ --BioScrip, Inc. (NASDAQ: BIOS)
today announced that at BioScrip's 2014 Annual Meeting held on May 8, 2014,
its stockholders voted to elect new independent director Yon Y. Jorden,
expanding the size of the Board of Directors from nine to ten members, nine of
whom are independent and all of whom are elected annually.

Ms. Jorden has more than a decade of leadership experience in health care
services and has served as Chief Financial Officer for several publicly-traded
health care companies over her career, including AdvancePCS, Oxford Health
Plans, Inc. and Wellpoint, Inc. She also has additional expertise across the
technology and manufacturing industries. Throughout her career, Ms. Jorden has
focused on complex financial transactions, including initial public offerings
and mergers and acquisitions, which will bring additional valuable perspective
to the BioScrip Board. Ms. Jorden will serve on BioScrip's Audit Committee and
Management Development and Compensation Committee.

"Yon's extensive public company Board experience, strong financial background
and deep knowledge of healthcare will add considerable value to BioScrip's
execution of its ongoing strategic priorities," said Rick Smith, President and
Chief Executive Officer of BioScrip. "We believe BioScrip is a dynamic company
with strong growth potential in the infusion industry. Since the beginning of
the year, we have welcomed two highly qualified independent directors to our
Board, and we look forward to building on our recent success as we benefit
from Yon's perspective and expertise."

Ms. Jorden is a National Association of Corporate Directors (NACD) Board
Leadership Fellow and currently serves on the board of directors of Methodist
Health System, a Texas-based not-for-profit hospital system, and Maxwell
Technologies, Inc., a publicly-traded manufacturer of energy storage and power
delivery solutions. She previously served on the board of directors of
Magnetek, Inc. and U.S. Oncology. 

Caldwell Partners assisted BioScrip's Board with its director search process.

About BioScrip, Inc.

BioScrip, Inc. is a leading national provider of infusion and home care
solutions. BioScrip partners with physicians, hospital systems, healthcare
payors, and pharmaceutical manufacturers to provide patients access to
post-acute care services. BioScrip operates with a commitment to bring
customer-focused pharmacy and related healthcare infusion therapy services
into the home or alternate- site setting. By collaborating with the full
spectrum of healthcare professionals and the patient, BioScrip provides
cost-effective care that is driven by quality, customer service, and values
that promote positive outcomes and an enhanced quality of life for those it
serves. BioScrip provides its infusion and home care services from over 80
locations across 29 states.

Contact:
Hai Tran, Chief Financial Officer
BioScrip
952-979-3768

SOURCE BioScrip, Inc.
 
Press spacebar to pause and continue. Press esc to stop.